Resistant ascites treated by combined diuretic therapy (spironolactone, mannitol, and chlorothiazide). 1960

S SHALDON, and J R McLAREN, and S SHERLOCK

UI MeSH Term Description Entries
D008353 Mannitol A diuretic and renal diagnostic aid related to sorbitol. It has little significant energy value as it is largely eliminated from the body before any metabolism can take place. It can be used to treat oliguria associated with kidney failure or other manifestations of inadequate renal function and has been used for determination of glomerular filtration rate. Mannitol is also commonly used as a research tool in cell biological studies, usually to control osmolarity. (L)-Mannitol,Osmitrol,Osmofundin
D002740 Chlorothiazide A thiazide diuretic with actions and uses similar to those of HYDROCHLOROTHIAZIDE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p812)
D004232 Diuretics Agents that promote the excretion of urine through their effects on kidney function. Diuretic,Diuretic Effect,Diuretic Effects,Effect, Diuretic,Effects, Diuretic
D000450 Aldosterone A hormone secreted by the ADRENAL CORTEX that regulates electrolyte and water balance by increasing the renal retention of sodium and the excretion of potassium. Aldosterone, (+-)-Isomer,Aldosterone, (11 beta,17 alpha)-Isomer
D000451 Mineralocorticoid Receptor Antagonists Drugs that bind to and block the activation of MINERALOCORTICOID RECEPTORS by MINERALOCORTICOIDS such as ALDOSTERONE. Aldosterone Antagonist,Aldosterone Antagonists,Aldosterone Receptor Antagonist,Mineralocorticoid Antagonist,Mineralocorticoid Receptor Antagonist,Aldosterone Receptor Antagonists,Mineralocorticoid Antagonists,Antagonist, Aldosterone,Antagonist, Aldosterone Receptor,Antagonist, Mineralocorticoid,Antagonist, Mineralocorticoid Receptor,Antagonists, Aldosterone,Antagonists, Aldosterone Receptor,Antagonists, Mineralocorticoid,Antagonists, Mineralocorticoid Receptor,Receptor Antagonist, Aldosterone,Receptor Antagonist, Mineralocorticoid,Receptor Antagonists, Aldosterone,Receptor Antagonists, Mineralocorticoid
D001201 Ascites Accumulation or retention of free fluid within the peritoneal cavity.
D013148 Spironolactone A potassium sparing diuretic that acts by antagonism of aldosterone in the distal renal tubules. It is used mainly in the treatment of refractory edema in patients with congestive heart failure, nephrotic syndrome, or hepatic cirrhosis. Its effects on the endocrine system are utilized in the treatments of hirsutism and acne but they can lead to adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p827) Spirolactone,Aldactone,Aldactone A,Aquareduct,Duraspiron,Espironolactona Alter,Espironolactona Mundogen,Flumach,Frumikal,Jenaspiron,Novo-Spiroton,Practon,SC-9420,Spiractin,Spiro L.U.T.,Spiro Von Ct,Spirobeta,Spirogamma,Spirolang,Spirono-Isis,Spironone,Spirospare,Veroshpiron,Verospiron,Verospirone,Ct, Spiro Von,Novo Spiroton,NovoSpiroton,SC 9420,SC9420,Spirono Isis,Von Ct, Spiro

Related Publications

S SHALDON, and J R McLAREN, and S SHERLOCK
December 1964, American heart journal,
S SHALDON, and J R McLAREN, and S SHERLOCK
October 1960, Annals of the New York Academy of Sciences,
S SHALDON, and J R McLAREN, and S SHERLOCK
July 1963, Ugeskrift for laeger,
S SHALDON, and J R McLAREN, and S SHERLOCK
March 2012, Clinics in perinatology,
S SHALDON, and J R McLAREN, and S SHERLOCK
October 1963, Acta medica Scandinavica,
S SHALDON, and J R McLAREN, and S SHERLOCK
August 1986, Archives of internal medicine,
S SHALDON, and J R McLAREN, and S SHERLOCK
February 1963, Arizona medicine,
S SHALDON, and J R McLAREN, and S SHERLOCK
August 1961, The New England journal of medicine,
S SHALDON, and J R McLAREN, and S SHERLOCK
June 1959, Semaine medicale professionelle et medico-sociale,
S SHALDON, and J R McLAREN, and S SHERLOCK
June 1958, Lancet (London, England),
Copied contents to your clipboard!